Objective. To make a systematic review of the data available in the literature on the effect of
combined oral contraceptives with different progestogenic components on the risk of venous …

Combined hormonal contraception containing estrogen and progestogen and
postmenopausal hormone therapy with estrogen±progestogen are reported risk factors for …

Introduction: Women using oral hormonal contraceptives are exposed to an increased risk of
venous thromboembolism. The incidence of venous thromboembolism in women is difficult …

Despite the improvement and widespread use of hormonal contraceptives, both one of the
most reliable methods of contraception and a treatment for many gynecological diseases …

Combined oral contraceptives (COC) are the most popular contraceptive method in
developed countries. Since their introduction there have been numerous changes and …

The effect of progestin-only therapy on the haemostatic system has mainly been studied in
premenopausal women. Although these studies are difficult to compare, most authors agree …

Since the early 1960s, it has been well documented that combined hormonal contraceptives
increase the risk of cardiovascular disease. Newer generation of oral formulations, as well …

Hormonal contraceptive methods are widely used in France, including not only oral estrogen–
progestin combinations but also non-oral estrogen–progestin delivery methods (patches …

Several new observational studies have assessed the risk of venous and arterial thrombosis
in users of different types of hormonal contraception [1–5]. The new studies have confirmed …

The development of oral contraceptives (OCs) began in 1921 and continued in the following
years until the first regulatory approval from the Food and Drug Administration was granted …